caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1952811044

Yasser GedMBSS, MD

Medical OncologyBaltimore, MDI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
QUALITY · MIPS · 2024
Final MIPS score
83.3
Quality
73.9
Cost
70.5
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.35%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$7K
Payment records
10
By payment type
Consulting Fee$6K
Food and Beverage$625
Travel and Lodging$370
PRESCRIBING · PART D · 2024
Total Rx claims
193
Beneficiaries
—
Total drug cost
$3.0M
Distinct drugs
7
Brand share
81.3%
Top prescribed drugs
Cabozantinib S-Malate53 claims
Apixaban33 claims
Lenvatinib Mesylate28 claims
Belzutifan24 claims
Levothyroxine Sodium20 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
336
Unique beneficiaries
—
Total services
650
Distinct HCPCS
5
Medicare payment
$46K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 114 Medical Oncology providers in MD — above median (cohort median 578).